Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Annexin A2 (ANXA2)
100%
Annexin
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Herceptin
100%
Epidermal Growth Factor Receptor
100%
Resistant Breast Cancer
100%
Reciprocal Regulation
100%
Negative Breast Cancer
33%
Small Interfering RNA (siRNA)
22%
Cell Migration
22%
Cell Viability
22%
Downstream Signaling
22%
Apoptosis
11%
Cell Proliferation
11%
Overexpression
11%
Signaling Pathway
11%
Breast Cancer
11%
Signaling Complex
11%
Oncogenesis
11%
Signaling Cascades
11%
Receptor Tyrosine Kinase
11%
Proliferation Migration
11%
Therapeutic Value
11%
Induced Activation
11%
Membrane Binding
11%
Clinical Samples
11%
Membrane Translocation
11%
Epidermal Growth Factor Receptor Signaling
11%
Positive Regulation
11%
Expression Analysis
11%
Protein Analysis
11%
Breast Cancer Patients
11%
Triple-negative Breast Cancer
11%
RNA Analysis
11%
Immunohistochemical Expression
11%
Survival Pathways
11%
Receptor-mediated Endocytosis
11%
Biochemistry, Genetics and Molecular Biology
Annexin A2
100%
Epidermal Growth Factor Receptor
100%
Trastuzumab
100%
Lipocortin
100%
Downregulation
33%
Cell Migration
33%
Cell Viability
33%
Small Interfering RNA
33%
Cell Proliferation
16%
Upregulation
16%
RNA
16%
Receptor Tyrosine Kinase
16%
Expression Analysis
16%
Carcinogenesis
16%
Endocytosis
16%
Programmed Cell Death
16%